“Anti-tumor activity of cabozantinib by FAK down-regulation in human oral squamous cell carcinoma”, Bangladesh J Pharmacol, vol. 11, no. 1, pp. 119–125, Dec. 2015, doi: 10.3329/bjp.v11i1.24001.